Oriental Aromatics Limited Logo

Oriental Aromatics Limited

OAL.NS

(1.8)
Stock Price

541,00 INR

2.77% ROA

4.2% ROE

62.83x PER

Market Cap.

16.468.389.160,00 INR

32.27% DER

0.1% Yield

3.06% NPM

Oriental Aromatics Limited Stock Analysis

Oriental Aromatics Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Oriental Aromatics Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

ROE in an average range (6.6%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

5 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (13.998), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

6 ROA

The stock's ROA (0%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

7 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

Oriental Aromatics Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Oriental Aromatics Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Oriental Aromatics Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Oriental Aromatics Limited Revenue
Year Revenue Growth
2006 1.149.436.000
2007 1.046.300.000 -9.86%
2008 1.346.388.000 22.29%
2009 1.654.621.000 18.63%
2010 2.166.363.000 23.62%
2011 2.022.359.000 -7.12%
2012 2.168.151.000 6.72%
2013 3.093.295.000 29.91%
2014 3.550.574.000 12.88%
2015 3.509.176.000 -1.18%
2016 3.512.661.000 0.1%
2017 5.041.133.000 30.32%
2018 7.532.436.000 33.07%
2019 7.598.945.000 0.88%
2020 7.088.355.000 -7.2%
2021 8.663.537.000 18.18%
2022 8.490.726.000 -2.04%
2023 9.072.940.000 6.42%
2023 8.364.047.000 -8.48%
2024 8.630.328.000 3.09%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Oriental Aromatics Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 7.268.000 100%
2013 7.949.000 8.57%
2014 14.766.000 46.17%
2015 11.062.000 -33.48%
2016 23.207.000 52.33%
2017 43.608.000 46.78%
2018 86.200.000 49.41%
2019 93.629.000 7.93%
2020 72.916.000 -28.41%
2021 72.829.000 -0.12%
2022 82.474.000 11.69%
2023 0 0%
2023 69.908.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Oriental Aromatics Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 58.367.000
2007 56.851.000 -2.67%
2008 66.981.000 15.12%
2009 69.478.000 3.59%
2010 77.791.000 10.69%
2011 76.306.000 -1.95%
2012 9.130.000 -735.77%
2013 16.904.000 45.99%
2014 0 0%
2015 18.204.000 100%
2016 28.465.000 36.05%
2017 55.068.000 48.31%
2018 70.332.000 21.7%
2019 76.333.000 7.86%
2020 99.015.000 22.91%
2021 91.406.000 -8.32%
2022 528.882.000 82.72%
2023 0 0%
2023 506.394.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Oriental Aromatics Limited EBITDA
Year EBITDA Growth
2006 46.124.000
2007 39.417.000 -17.02%
2008 116.275.000 66.1%
2009 197.867.000 41.24%
2010 148.562.000 -33.19%
2011 115.907.000 -28.17%
2012 269.805.000 57.04%
2013 464.696.000 41.94%
2014 416.087.000 -11.68%
2015 504.512.000 17.53%
2016 534.763.000 5.66%
2017 654.552.000 18.3%
2018 1.166.988.000 43.91%
2019 1.295.639.000 9.93%
2020 1.564.822.000 17.2%
2021 955.269.000 -63.81%
2022 599.415.000 -59.37%
2023 555.360.000 -7.93%
2023 469.368.000 -18.32%
2024 884.056.000 46.91%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Oriental Aromatics Limited Gross Profit
Year Gross Profit Growth
2006 154.889.000
2007 156.213.000 0.85%
2008 212.027.000 26.32%
2009 229.422.000 7.58%
2010 203.794.000 -12.58%
2011 283.056.000 28%
2012 532.349.000 46.83%
2013 710.664.000 25.09%
2014 699.759.000 -1.56%
2015 808.092.000 13.41%
2016 905.853.000 10.79%
2017 1.217.599.000 25.6%
2018 1.909.279.000 36.23%
2019 2.115.281.000 9.74%
2020 2.357.565.000 10.28%
2021 1.887.963.000 -24.87%
2022 1.624.317.000 -16.23%
2023 1.420.432.000 -14.35%
2023 794.724.000 -78.73%
2024 1.311.852.000 39.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Oriental Aromatics Limited Net Profit
Year Net Profit Growth
2006 16.803.000
2007 4.910.000 -242.22%
2008 36.977.000 86.72%
2009 102.424.000 63.9%
2010 76.513.000 -33.86%
2011 21.234.000 -260.33%
2012 239.381.000 91.13%
2013 201.081.000 -19.05%
2014 192.564.000 -4.42%
2015 226.864.000 15.12%
2016 241.543.000 6.08%
2017 249.816.000 3.31%
2018 571.432.000 56.28%
2019 861.889.000 33.7%
2020 1.019.376.000 15.45%
2021 533.023.000 -91.24%
2022 197.429.000 -169.98%
2023 100.168.000 -97.1%
2023 91.042.000 -10.02%
2024 439.208.000 79.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Oriental Aromatics Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 1
2007 0 0%
2008 2 100%
2009 5 75%
2010 4 -33.33%
2011 1 -200%
2012 12 90.91%
2013 10 -22.22%
2014 19 50%
2015 11 -63.64%
2016 8 -37.5%
2017 7 -14.29%
2018 17 56.25%
2019 26 36%
2020 30 16.67%
2021 16 -100%
2022 6 -200%
2023 3 -150%
2023 3 0%
2024 13 84.62%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Oriental Aromatics Limited Free Cashflow
Year Free Cashflow Growth
2006 47.923.000
2007 -35.087.000 236.58%
2008 -63.654.000 44.88%
2009 -3.418.000 -1762.32%
2010 -215.836.000 98.42%
2011 1.698.000 12811.19%
2012 -939.794.000 100.18%
2013 252.510.000 472.18%
2014 109.644.000 -130.3%
2015 254.463.000 56.91%
2016 223.059.000 -14.08%
2017 -148.017.000 250.7%
2018 -362.887.000 59.21%
2019 1.710.585.000 121.21%
2020 -176.854.000 1067.23%
2021 -603.086.000 70.68%
2022 -689.986.000 12.59%
2023 214.549.000 421.6%
2023 0 0%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Oriental Aromatics Limited Operating Cashflow
Year Operating Cashflow Growth
2006 61.518.000
2007 15.395.000 -299.6%
2008 -47.044.000 132.72%
2009 48.374.000 197.25%
2010 -175.759.000 127.52%
2011 142.533.000 223.31%
2012 -139.292.000 202.33%
2013 312.899.000 144.52%
2014 172.535.000 -81.35%
2015 418.393.000 58.76%
2016 420.996.000 0.62%
2017 160.263.000 -162.69%
2018 -234.229.000 168.42%
2019 1.809.425.000 112.94%
2020 173.414.000 -943.41%
2021 -8.136.000 2231.44%
2022 -223.002.000 96.35%
2023 1.208.221.000 118.46%
2023 0 0%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Oriental Aromatics Limited Capital Expenditure
Year Capital Expenditure Growth
2006 13.595.000
2007 50.482.000 73.07%
2008 16.610.000 -203.93%
2009 51.792.000 67.93%
2010 40.077.000 -29.23%
2011 140.835.000 71.54%
2012 800.502.000 82.41%
2013 60.389.000 -1225.58%
2014 62.891.000 3.98%
2015 163.930.000 61.64%
2016 197.937.000 17.18%
2017 308.280.000 35.79%
2018 128.658.000 -139.61%
2019 98.840.000 -30.17%
2020 350.268.000 71.78%
2021 594.950.000 41.13%
2022 466.984.000 -27.4%
2023 993.672.000 53%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Oriental Aromatics Limited Equity
Year Equity Growth
2006 531.123.000
2007 522.737.000 -1.6%
2008 550.706.000 5.08%
2009 644.148.000 14.51%
2010 711.711.000 9.49%
2011 732.917.000 2.89%
2012 972.298.000 24.62%
2013 1.161.366.000 16.28%
2014 1.339.179.000 13.28%
2015 1.556.774.000 13.98%
2016 1.798.317.000 13.43%
2017 3.375.753.000 46.73%
2018 3.919.242.000 13.87%
2019 4.641.398.000 15.56%
2020 5.572.867.000 16.71%
2021 6.052.200.000 7.92%
2022 6.249.428.000 3.16%
2023 6.323.486.000 1.17%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Oriental Aromatics Limited Assets
Year Assets Growth
2006 732.889.000
2007 795.796.000 7.9%
2008 892.884.000 10.87%
2009 1.043.582.000 14.44%
2010 1.399.541.000 25.43%
2011 2.009.040.000 30.34%
2012 2.636.107.000 23.79%
2013 2.979.649.000 11.53%
2014 3.138.737.000 5.07%
2015 3.161.287.000 0.71%
2016 3.209.651.000 1.51%
2017 5.728.981.000 43.98%
2018 6.725.411.000 14.82%
2019 6.083.021.000 -10.56%
2020 7.449.960.000 18.35%
2021 8.648.780.000 13.86%
2022 9.864.622.000 12.33%
2023 9.949.544.000 0.85%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Oriental Aromatics Limited Liabilities
Year Liabilities Growth
2006 201.766.000
2007 273.059.000 26.11%
2008 342.178.000 20.2%
2009 399.434.000 14.33%
2010 687.830.000 41.93%
2011 1.276.123.000 46.1%
2012 1.663.809.000 23.3%
2013 1.818.283.000 8.5%
2014 1.799.558.000 -1.04%
2015 1.604.513.000 -12.16%
2016 1.411.334.000 -13.69%
2017 2.353.228.000 40.03%
2018 2.806.169.000 16.14%
2019 1.441.623.000 -94.65%
2020 1.877.093.000 23.2%
2021 2.596.580.000 27.71%
2022 3.615.194.000 28.18%
2023 3.626.058.000 0.3%

Oriental Aromatics Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
254.5
Net Income per Share
7.79
Price to Earning Ratio
62.83x
Price To Sales Ratio
1.92x
POCF Ratio
83.19
PFCF Ratio
83.19
Price to Book Ratio
2.6
EV to Sales
2.15
EV Over EBITDA
25.15
EV to Operating CashFlow
92.93
EV to FreeCashFlow
92.93
Earnings Yield
0.02
FreeCashFlow Yield
0.01
Market Cap
16,47 Bil.
Enterprise Value
18,40 Bil.
Graham Number
181.46
Graham NetNet
-21.85

Income Statement Metrics

Net Income per Share
7.79
Income Quality
0.76
ROE
0.04
Return On Assets
0.03
Return On Capital Employed
0.07
Net Income per EBT
0.71
EBT Per Ebit
0.69
Ebit per Revenue
0.06
Effective Tax Rate
0.29

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0.01
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.16
Operating Profit Margin
0.06
Pretax Profit Margin
0.04
Net Profit Margin
0.03

Dividends

Dividend Yield
0
Dividend Yield %
0.1
Payout Ratio
0
Dividend Per Share
0.5

Operating Metrics

Operating Cashflow per Share
5.88
Free CashFlow per Share
5.88
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.05
Return on Tangible Assets
0.03
Days Sales Outstanding
76.94
Days Payables Outstanding
41.76
Days of Inventory on Hand
141.24
Receivables Turnover
4.74
Payables Turnover
8.74
Inventory Turnover
2.58
Capex per Share
0

Balance Sheet

Cash per Share
4,48
Book Value per Share
187,90
Tangible Book Value per Share
173.06
Shareholders Equity per Share
187.9
Interest Debt per Share
66.54
Debt to Equity
0.32
Debt to Assets
0.21
Net Debt to EBITDA
2.64
Current Ratio
1.9
Tangible Asset Value
5,82 Bil.
Net Current Asset Value
1,66 Bil.
Invested Capital
6938993000
Working Capital
2,50 Bil.
Intangibles to Total Assets
0.05
Average Receivables
0,90 Bil.
Average Payables
0,41 Bil.
Average Inventory
1385847000
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Oriental Aromatics Limited Dividends
Year Dividends Growth
2020 3
2021 2 -100%
2023 1 0%
2024 1 0%

Oriental Aromatics Limited Profile

About Oriental Aromatics Limited

Oriental Aromatics Limited manufactures and sells terpene chemicals, camphor, and other specialty aroma Ingredients in India. It offers specialty aroma chemicals for use in flavours, fragrances, and essential oils; synthetic camphor for medicinal and religious application; and terpineol, pine oils, astromusk, isobornyl acetate, and terpene resins. The company also provides fragrances for soaps, shampoos, hair oils, detergents, incense sticks, cosmetics and toiletries, household cleaners, air fresheners, etc.; and flavors for instant food, beverages, dairy, confectionery, oral hygiene, sweets, meat, snacks, healthcare, and bakery industries. In addition, it exports its products to Mexico, the United States, Argentina, Brazil, Colombia, France, Geneva, Germany, the Netherlands, Portugal, Spain, Switzerland, Turkey, the United Kingdom, Ukraine, Egypt, Nigeria, Bangladesh, China, Hong Kong, Indonesia, Japan, Malaysia, Myanmar, Oman, Pakistan, Singapore, Sri Lanka, Thailand, the United Arab Emirates, Vietnam, and Yemen. The company was formerly known as Camphor & Allied Products Limited and changed its name to Oriental Aromatics Limited in February 2018. Oriental Aromatics Limited was founded in 1955 and is headquartered in Mumbai, India.

CEO
Mr. Parag K. Satoskar
Employee
735
Address
133 Jehangir Building
Mumbai, 400001

Oriental Aromatics Limited Executives & BODs

Oriental Aromatics Limited Executives & BODs
# Name Age
1 Ms. Anita Parag Satoskar
Chief Technology Officer
70
2 Mr. Satish Kumar Ray
Executive Director of Operations & Whole Time Director
70
3 Mr. Dharmil Anil Bodani
Chairman & MD
70
4 Mr. Parag K. Satoskar
Chief Executive Officer
70
5 Mr. Girish Khandelwal
Chief Financial Officer
70
6 Ms. Kiranpreet Kaur Gill
Company Secretary & Compliance Officer
70
7 Mr. Shyamal Anil Bodani
Executive Director
70

Oriental Aromatics Limited Competitors

Neogen Chemicals Limited Logo
Neogen Chemicals Limited

NEOGEN.NS

(2.5)
Amrutanjan Health Care Limited Logo
Amrutanjan Health Care Limited

AMRUTANJAN.NS

(2.8)
Apollo Pipes Limited Logo
Apollo Pipes Limited

APOLLOPIPE.NS

(2.5)
Galaxy Surfactants Limited Logo
Galaxy Surfactants Limited

GALAXYSURF.NS

(3.5)